Global players in peptide business.
1. Bachem
2. Polypeptide
3. Corden Pharma
4. AmbioPharm
Bachem
World's leading peptide CDMO.
150+ NCE Projects
1600+ employees across 6 locations
Expertise on Peptide NCEs & Oligonucleotide NCEs.
bachem.com/download/326/n…
bachem.com/download/180/b…
bachem.com/download/180/b…
Polypeptide
Leader in outsourced peptide manufacturing.
Produces around half of the commercially aproved peptides.
6 GMP certified facilities including one in Ambernath, India.
1000+ employees
group.polypeptide.com/app/uploads/20…
Strong demand for peptide drugs.
Piramal pharma looks good on peptide space than Neuland on DMF filings.
Neuland have 4 peptides under development, that too on early development phase & expects to file a DMF may be in the end of FY23.
(They had started developing these peptides from 2018)
These are the 4 peptides Neuland is working on in the generic space.
@rahuja671 has pointed out that there are only 3 peptides on the R&D pipeline of Neuland on the most recent API product list. (Jan 2022)
That means they might have omitted the peptide Octreotide from their pipeline.
Neuland had been working on this molecule for the past 4 years and yet they couldn't commercialise it and now they have omitted it from pipeline.
Don't know the exact reason for that and couldn't find anything about that in past concalls.
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.